
THTX
Theratechnologies Inc.
$3.32
+$0.01(+0.30%)
100
Overall
--
Value
100
Tech
--
Quality
Market Cap
$151.21M
Volume
533.70K
52W Range
$1.12 - $3.34
Target Price
$5.92
Order:
Income Statement
Metric | Trend | Chart | 2019 Nov | 2020 Nov | 2021 Nov | 2022 Nov | 2023 Nov | 2024 Nov |
---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||
Total Revenue | $63.2M | $66.1M | $69.8M | $80.1M | $81.8M | $85.9M | ||
Total Revenue | $63.2M | $66.1M | $69.8M | $80.1M | $81.8M | $85.9M | ||
COST OF GOODS SOLD | ||||||||
Cost of Revenue | $26.1M | $26.9M | $23.3M | $26.3M | $19.6M | $20.4M | ||
GROSS PROFIT | ||||||||
Gross Profit | $37.1M | $39.2M | $46.6M | $53.8M | $62.1M | $65.4M | ||
OPERATING EXPENSES | ||||||||
Operating Expenses | $45.7M | $57.1M | $71.8M | $96.1M | $72.8M | $57.2M | ||
Research & Development | $10.8M | $18.0M | $28.3M | $36.9M | $30.4M | $17.0M | ||
Research Expense | -- | -- | -- | $36.9M | $30.4M | $17.0M | ||
Selling, General & Administrative | $34.8M | $39.1M | $43.5M | $56.7M | $42.4M | $40.3M | ||
Selling & Marketing Expenses | $26.5M | $26.9M | $28.9M | $39.4M | $26.8M | $25.4M | ||
General & Administrative Expenses | $8.3M | $12.2M | $14.6M | $17.4M | $15.6M | $14.9M | ||
Depreciation & Amortization | -- | -- | -- | $2.4M | -- | -- | ||
Depreciation & Amortization | -- | -- | -- | $2.4M | -- | -- | ||
Amortization | -- | -- | -- | $2.4M | -- | -- | ||
OPERATING INCOME | ||||||||
Operating income | $-8.5M | $-18.0M | $-25.2M | $-39.9M | $-10.6M | $8.2M | ||
EBITDA | $-11.0K | $-8.7M | $-17.3M | $-27.8M | $-5.2M | $12.9M | ||
NON-OPERATING ITEMS | ||||||||
Interest Expense (Non-Operating) | $5.0M | $5.4M | $5.7M | $6.5M | $15.1M | $16.5M | ||
Intinc | $1.1M | $717.0K | $195.0K | $316.0K | $2.1M | $2.0M | ||
Net Non-Operating Interest Income/Expense | $3.9M | $4.7M | $5.5M | $-4.1M | $-12.9M | $-14.5M | ||
Gain on Sale of Securities | $-51.0K | $409.0K | $-926.0K | -- | $1.3M | -- | ||
Other Income/Expense | $-51.0K | $409.0K | $-926.0K | $1.8M | $4.3M | -- | ||
Other Special Charges | -- | -- | -- | $-1.8M | $-5.5M | -- | ||
SPECIAL ITEMS | ||||||||
Special Income Charges | -- | -- | -- | -- | $-954.0K | -- | ||
PRE-TAX INCOME | ||||||||
EBIT | $-7.5M | $-17.2M | $-26.0M | $-40.3M | $-8.5M | $10.2M | ||
Pre-Tax Income | $-12.5M | $-22.7M | $-31.7M | $-46.8M | $-23.5M | $-6.3M | ||
INCOME TAX | ||||||||
Tax Provision | -- | $16.0K | $63.0K | $443.0K | $421.0K | $2.0M | ||
NET INCOME | ||||||||
Net Income | $-12.5M | $-22.7M | $-31.7M | $-47.2M | $-24.0M | $-8.3M | ||
Net Income (Continuing Operations) | $-12.5M | $-22.7M | $-31.7M | $-47.2M | $-24.0M | $-8.3M | ||
Net Income (Discontinued Operations) | $-12.5M | $-22.7M | $-31.7M | $-47.2M | $-24.0M | $-8.3M | ||
Net Income (Common Stockholders) | $-12.5M | $-22.7M | $-31.7M | $-47.2M | $-24.0M | $-8.3M | ||
Normalized Income | $-9.2M | $-16.6M | $-23.3M | $-34.4M | $-17.3M | $-6.2M | ||
TOTALS | ||||||||
Total Expenses | $-71.7M | $-84.0M | $-95.1M | $120.0M | $92.4M | $77.7M | ||
SHARE & EPS DATA | ||||||||
Average Shares Outstanding | $76.9M | $77.0M | $92.4M | $95.1M | $26.3M | $49.4M | ||
Average Shares Outstanding (Diluted) | $76.9M | $77.0M | $92.4M | $95.3M | $26.3M | $49.4M | ||
Shares Outstanding | $77.0M | $77.0M | $95.1M | $94.7M | $46.0M | $46.0M | ||
Basic EPS | $-0.16 | $-0.29 | $-0.34 | $-0.50 | $-0.91 | $-0.17 | ||
Basic EPS (Continuing Operations) | $-0.16 | $-0.29 | $-0.34 | $-0.50 | $-0.91 | $-0.17 | ||
Diluted EPS | $-0.16 | $-0.29 | $-0.34 | $-0.50 | $-0.91 | $-0.17 | ||
Diluted EPS (Continuing Operations) | $-0.16 | $-0.29 | $-0.34 | $-0.50 | $-0.91 | $-0.17 | ||
OTHER METRICS | ||||||||
Other Costof Revenue | -- | -- | -- | $23.8M | $19.6M | $20.4M | ||
Other Gand A | $8.3M | $12.2M | $14.6M | $17.4M | $15.6M | $14.9M | ||
Write Off | -- | -- | -- | -- | $954.0K | -- |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | THTX | $3.32 | +0.3% | 533.70K |
3 | ||||
4 | ||||
5 | ||||
6 |